Imara to webcast conference call of second quarter 2021 financial results and business highlights

Boston, july 30, 2021 (globe newswire) -- imara inc. (nasdaq: imra), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced that the company will host a conference call and live webcast on friday, august 6, 2021, at 8:30 a.m. et to discuss its financial results for the quarter ended june 30, 2021 and review recent business highlights.
ELVN Ratings Summary
ELVN Quant Ranking